Intercostal Nerve Cryoablation in Minimally Invasive Repair of Pectus Excavatum: National Trends, Outcomes, and Predictors of Utilization
Topic overview
This study examines national adoption patterns of intercostal nerve cryoablation as an adjunct pain control method during minimally invasive pectus excavatum repair (MIRPE/Nuss procedure). The analysis evaluates clinical outcomes and identifies factors influencing surgeon utilization of this technique amid ongoing insurance reimbursement controversies.
Key takeaways
- Intercostal nerve cryoablation is an effective pain control technique during MIRPE but faces reimbursement challenges from insurers.
- Some insurers classify cryoablation as experimental, limiting coverage despite clinical evidence of efficacy.
- National utilization patterns vary, suggesting inconsistent adoption across institutions and regions.
- Understanding predictors of cryoablation use can inform standardization and reimbursement advocacy efforts.
- Outcomes data support cryoablation's role in multimodal pain management for pectus excavatum repair.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Intercostal Nerve Cryoablation in Minimally Invasive Repair of Pectus Excavatum: National Trends, Outcomes, and Predictors of Utilization. GlobalCastMD Medical Library. 2024-11-07. https://dev.library.globalcastmd.com/article/9403?via_space=staycurrentmd
Comments